Welcome back,

CONFERENCE UPDATE

AAAAI 2024

The 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

February 23-26, 2024 |

Washington, USA

2024

Improving asthma remission with benralizumab in real-world asthma patients in the US: Results from the ZEPHYR-4 study
DERMATOLOGY

8 May 2025
Omalizumab shows potential against multiple food allergies: Stage 1 findings from the OUtMATCH study
IMMUNOLOGY & ALLERGY

30 May 2024
Interim analysis of the real-world CHOPIN study shows reduction in HAE attacks and improvement in PROs with lanadelumab
IMMUNOLOGY & ALLERGY

30 May 2024
Navigating the spectrum of food refusal in children with IgE-mediated and non-IgE-mediated allergies
8 May 2024
Symptom reduction and QoL improvement in CRSwNP patients with mepolizumab: Results from the phase 3 SYNAPSE trial
8 May 2024
The role of TRP channels in the pathophysiology of nasal hyperreactivity and their potential as a treatment target
DERMATOLOGY

8 May 2024
Determining the diagnostic vital sign parameters in pediatric oral food challenges: Results from a US-based retrospective study
PEDIATRICS

15 Apr 2024
Impact of high-fat diet on skin microbiome in pediatric patients with food allergies and eczema

PEDIATRICS
|
DERMATOLOGY

15 Apr 2024
Identifying high-risk infants for AD through early skin microbiome and metabolome signatures: A sub-cohort analysis of the S-PRESTO study
DERMATOLOGY

15 Apr 2024

eaa0190a-4510-467f-900f-c94c7b668484